ArticleEuropean radiology2017

Assessment of response to anti-angiogenic targeted therapy in pulmonary metastatic renal cell carcinoma: R2* value as a predictive biomarker.

Guangyu Wu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.